UFC fighters Kevin Casey and Robert Drysdale have both failed their post-fight drug tests following their bouts on fourth of July weekend.
Casey, who finished Bubba Bush in the first round of their UFC 175 bout, tested positive for drostanolone, an anabolic steroid. Drysdale, who fought at The Ultimate Fighter 19 Finale, submitting Keith Berish in round one, once again failed a drug test for elevated levels of testosterone.
The UFC released a statement regarding the failed drug tests of both Casey and Drysdale:
The UFC has been notified by the Nevada State Athletic Commission that UFC middleweight Kevin Casey and light heavyweight Robert Drysdale failed drug tests following their fights at UFC 175 and The Ultimate Fighter Finale, respectively. Casey tested positive for drostanolone and Drysdale was flagged for an elevated testosterone-to-epitestosterone ratio. Both fighters have been temporarily suspended from competition and informed their positive tests violated the UFC Fighter Conduct Policy and Promotional Agreement with Zuffa, LLC. The UFC has a strict, consistent policy against the use of any illegal and/or performance-enhancing drugs, stimulants or masking agents by our athletes and will support the NSAC’s determination pending a formal hearing at a later date.